Tirzepatide represents a groundbreaking therapeutic agent for individuals facing type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://berthamqtt058624.dm-blog.com/40823843/tirzepatide-a-game-changer-for-type-2-diabetes